Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis.

Marta SantistebanBelén Pérez SolansLaura HatoAmaia UrrizolaLuis Daniel MejíasEsteban SalgadoRodrigo Sánchez-BayonaEstefanía ToledoNatalia Rodríguez-SpiteriBegoña OlartecoecheaMiguel Angel IdoateAscensión López-Díaz de CerioSusana Inogés

Published in: Therapeutic advances in medical oncology (2021)

ClinicalTrials.gov number: NCT01431196. EudraCT 2009-017402-36.

Keyphrases

neoadjuvant chemotherapy
dendritic cells
locally advanced
lymph node
sentinel lymph node
regulatory t cells
rectal cancer
immune response